Caribou Biosciences, Inc. (CRBU)

NASDAQ: CRBU · Real-Time Price · USD

1.820

+0.110 (6.43%)

Mar 6, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Developing a Pipeline of Allogeneic CAR-T and CAR-NK Cell Therapies		9.99M	34.48M	13.85M	9.60M	12.36M
Developing a Pipeline of Allogeneic CAR-T and CAR-NK Cell Therapies Growth		-71.01%	148.91%	44.31%	-22.35%	113.56%
Total		9.99M	34.48M	13.85M	9.60M	12.36M
Total Growth		-71.01%	148.91%	44.31%	-22.35%	113.56%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States		9.27M	32.77M	13.30M	8.91M	12.00M
United States Growth		-71.71%	146.34%	49.25%	-25.74%	124.40%
Rest of World		724.00K	1.71M	548.00K	685.00K	358.00K
Rest of World Growth		-57.59%	211.50%	-20.00%	91.34%	-18.45%
Total		9.99M	34.48M	13.85M	9.60M	12.36M
Total Growth		-71.01%	148.91%	44.31%	-22.35%	113.56%

Source: S&P Global Market Intelligence.